3D Broncho-Epithelial Tissue Assemblies via Rotating Wall Vessel Culture
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current in vitro models of human respiratory epithelium lack fidelity and longevity, failing to accurately replicate the structural and functional characteristics of in vivo tissues, particularly in larger scales and long-term cultures.
Innovation Solution
The development of three-dimensional (3D) human broncho-epithelial tissue-like assemblies (TLAs) using primary mesenchymal hBTCs as a foundation matrix and an adult HBE immortalized cell line BEAS-2B, cultured in Rotating Wall Vessels (RWVs) with collagen-coated cyclodextran microcarriers, which allows for the formation of well-differentiated, large-scale, and long-lasting tissue models that mimic in vivo respiratory epithelium.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional two-dimensional monolayer cultures or air-liquid interface cultures are used, then the model is simple to maintain, but the fidelity to in vivo respiratory epithelium structure and function deteriorates
Solution Approach 1:
The patent transitions from traditional two-dimensional monolayer cultures to three-dimensional tissue-like assemblies. The 3D architecture is achieved by culturing cells in rotating wall vessels that simulate microgravity, allowing cells to self-organize into pseudo-stratified epithelial structures with basement membrane and mesenchymal layers, thereby improving fidelity to in vivo respiratory epithelium while maintaining cultural simplicity through automated rotation.
Solution Approach 2:
The patent changes the physical parameters of the culture system by using rotating wall vessels to create a microgravity-like environment. This parameter change (rotation speed, gravity vector randomization) enables cells to form 3D structures with proper differentiation and tissue organization, improving model fidelity without requiring complex manual intervention.
2Reliability
If primary isolates of HBE cells are used to achieve pseudo-differentiated model, then the structural and functional fidelity improves, but the culture longevity deteriorates
Solution Approach 1:
The patent creates a composite tissue model consisting of multiple cell types (ciliated, secretory, and basal epithelial cells) organized in a pseudo-stratified architecture with basement membrane and underlying mesenchymal cells. This composite structure maintains functional fidelity while the rotating wall vessel culture system extends culture longevity by providing optimized nutrient delivery and waste removal in a 3D configuration.
Solution Approach 2:
The patent introduces dynamic culture conditions through continuous rotation of the wall vessel, which randomizes the gravity vector and creates a constantly changing fluid environment. This dynamic system prevents cell degradation over time, maintaining tissue fidelity for extended periods compared to static culture methods.
3Reliability
If air-liquid interface cultures are used to mimic fidelity of human respiratory epithelium, then the differentiation quality improves, but the scalability and ease of operation deteriorates
Solution Approach 1:
The rotating wall vessel system serves multiple functions simultaneously: it provides 3D culture geometry, creates microgravity-like conditions, enables automated nutrient distribution, and maintains air-liquid interface conditions. This multi-functional system achieves high differentiation quality while simplifying operation through automation, allowing scalable production of 3D tissue assemblies.
Solution Approach 2:
The rotating wall vessel system enables self-service culture maintenance through automated rotation that continuously distributes nutrients and removes waste products. The system self-regulates fluid dynamics and oxygen delivery, reducing manual intervention requirements while maintaining high differentiation quality of the epithelial tissues.
4Shape
If 3D aggregates are used to improve upon two-dimensional cultures, then the structural characteristics improve, but the functional fidelity and cellular relationships deteriorate
Solution Approach 1:
The patent creates local quality variations within the 3D tissue assembly by establishing distinct cellular zones: a pseudo-stratified epithelial layer with apical-basolateral polarity, a basement membrane zone, and underlying mesenchymal cell layers. Each zone maintains specific functional characteristics appropriate to its in vivo counterpart, ensuring functional fidelity while preserving 3D structural advantages.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach results in a physiologically relevant model that maintains functional cell markers for over 40 days, supports viral production and cellular repair, and allows for extensive analysis, enabling improved understanding and treatment of respiratory infections and diseases.
Implementation Method 1
This technology allows the recapitulated tissues to be used as host targets for viral infectivity (Goodwin et al., 2000) by providing controlled supplies of oxygen and nutrients, with minimal turbulence and extremely low shear (Schwarz et al, 1992). These vessels rotate the wall and culture media inside at identical angular velocity, thus continuously randomizing the gravity vector and holding particles such as microcarriers and cells relatively motionless in a quiescent fluid
Implementation Method 2
The construction of a functionally accurate, large-scale, 3D in vitro tissue model of the human airway is a major advance for lung research. The recapitulation of large TLAs that express differentiated epithelial and mesenchymal cell markers offers a multitude of possibilities for cell biological investigations.
Data Source
AI summary
Three-dimensional human broncho-epithelial tissue-like assemblies (TLAs) are produced in a rotating wall vessel (RWV) with microcarriers by coculturing mesenchymal bronchial-tracheal cells (BTC) and bronchial epithelium cells (BEC). These TLAs display structural characteristics and express markers of in vivo respiratory epithelia. TLAs are useful for screening compounds active in lung tissues such as antiviral compounds, cystic fibrosis treatments, allergens, and cytotoxic compounds.